Multi-event April 2023 FDA Recall Drug by Central Admixture Pharmacy Services, Inc.

This Multi-event Class II drug recall was voluntarily initiated by Central Admixture Pharmacy Services, Inc. on April 28, 2023 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Reported Recall Events

D-0753-2023 TERMINATED D-0730-2023 TERMINATED D-0676-2023 TERMINATED D-0741-2023 TERMINATED D-0726-2023 TERMINATED D-0655-2023 TERMINATED D-0738-2023 TERMINATED D-0694-2023 TERMINATED D-0665-2023 TERMINATED D-0656-2023 TERMINATED D-0717-2023 TERMINATED D-0672-2023 TERMINATED D-0673-2023 TERMINATED D-0654-2023 TERMINATED D-0649-2023 TERMINATED D-0705-2023 TERMINATED D-0661-2023 TERMINATED D-0725-2023 TERMINATED D-0708-2023 TERMINATED D-0700-2023 TERMINATED D-0691-2023 TERMINATED D-0740-2023 TERMINATED D-0651-2023 TERMINATED D-0662-2023 TERMINATED D-0707-2023 TERMINATED D-0734-2023 TERMINATED D-0677-2023 TERMINATED D-0718-2023 TERMINATED D-0745-2023 TERMINATED D-0652-2023 TERMINATED D-0669-2023 TERMINATED D-0728-2023 TERMINATED D-0722-2023 TERMINATED D-0729-2023 TERMINATED D-0748-2023 TERMINATED D-0754-2023 TERMINATED D-0701-2023 TERMINATED D-0670-2023 TERMINATED D-0699-2023 TERMINATED D-0689-2023 TERMINATED D-0695-2023 TERMINATED D-0716-2023 TERMINATED D-0685-2023 TERMINATED D-0650-2023 TERMINATED D-0698-2023 TERMINATED D-0713-2023 TERMINATED D-0733-2023 TERMINATED D-0684-2023 TERMINATED D-0743-2023 TERMINATED D-0671-2023 TERMINATED D-0742-2023 TERMINATED D-0714-2023 TERMINATED D-0702-2023 TERMINATED D-0674-2023 TERMINATED D-0721-2023 TERMINATED D-0687-2023 TERMINATED D-0709-2023 TERMINATED D-0706-2023 TERMINATED D-0710-2023 TERMINATED D-0682-2023 TERMINATED D-0703-2023 TERMINATED D-0712-2023 TERMINATED D-0752-2023 TERMINATED D-0747-2023 TERMINATED D-0667-2023 TERMINATED D-0746-2023 TERMINATED D-0664-2023 TERMINATED D-0648-2023 TERMINATED D-0744-2023 TERMINATED D-0688-2023 TERMINATED D-0737-2023 TERMINATED D-0736-2023 TERMINATED D-0659-2023 TERMINATED D-0751-2023 TERMINATED D-0668-2023 TERMINATED D-0750-2023 TERMINATED D-0696-2023 TERMINATED D-0658-2023 TERMINATED D-0683-2023 TERMINATED D-0686-2023 TERMINATED D-0653-2023 TERMINATED D-0697-2023 TERMINATED D-0675-2023 TERMINATED D-0693-2023 TERMINATED D-0723-2023 TERMINATED D-0678-2023 TERMINATED D-0739-2023 TERMINATED D-0657-2023 TERMINATED D-0755-2023 TERMINATED D-0663-2023 TERMINATED D-0724-2023 TERMINATED D-0704-2023 TERMINATED D-0666-2023 TERMINATED D-0720-2023 TERMINATED D-0715-2023 TERMINATED D-0690-2023 TERMINATED D-0660-2023 TERMINATED D-0679-2023 TERMINATED D-0727-2023 TERMINATED D-0711-2023 TERMINATED D-0681-2023 TERMINATED D-0735-2023 TERMINATED D-0719-2023 TERMINATED D-0749-2023 TERMINATED D-0732-2023 TERMINATED D-0680-2023 TERMINATED D-0731-2023 TERMINATED D-0692-2023 TERMINATED

Recall Number: D-0753-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
1516 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Lidocaine 2% HCl Inj, 500mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8091-1, code 7128580911.

Batch or Lot Expiration Information

Lot# 37-870983, Exp 06/10/2023; 37-879653, 37-879654, Exp 07/16/2023; 37-883186, Exp 07/29/2023; 37-888533, Exp 08/20/2023; 37-893416, Exp 09/09/2023

Recall Number: D-0730-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
2542 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
EPINEPHrine added to dextrose 5%, 8 mg/250 mL* (32 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7019-1.

Batch or Lot Expiration Information

Lot# 37-884156, Exp 05/03/2023; 37-885207, Exp 05/08/2023; 37-885929, Exp 05/10/2023; 37-886496, Exp 05/14/2023; 37-886817, Exp 05/15/2023; 37-887420, Exp 05/16/2023; 37-893786, Exp 06/12/2023; 37-894303, Exp 06/13/2023; 37-897893, Exp 06/27/2023; 37-900073, Exp 07/05/2023

Recall Number: D-0676-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
52 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Induction 4:1 Plasmalyte, HIGH POTASSIUM, HIGH K, packaged in 542 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0212-1.

Batch or Lot Expiration Information

Lot# 37-895217, Exp 05/04/2023; 37-898803, Exp 05/18/2023; 37-900614, Exp 05/25/2023

Recall Number: D-0741-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
225 syringes

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
tromethamine 0.3 Molar, 50 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8086-2.

Batch or Lot Expiration Information

Lot# 37-884580, Exp 05/04/2023; 37-887061, Exp 05/15/2023; 37-892981, Exp 06/07/2023

Recall Number: D-0726-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
3055 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
heparin added to 0.9% sodium chloride, 7,500 units/1,000 mL* (7.5 units/mL), 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7009-1.

Batch or Lot Expiration Information

Lot# 37-888668, 37-888685, 37-888701, Exp 05/02/2023; 37-890550, 37-890556, Exp 05/09/2023; 37-892201, 37-892216, Exp 05/16/2023; 37-893866, 37-893917, 37-893918, Exp 05/23/2023; 37-895705, 37-895717, Exp 05/30/2023

Recall Number: D-0655-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
12 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Warm Induction 4:1 HIGH POTASSIUM/low tromethamine, 40 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0011-1.

Batch or Lot Expiration Information

Lot# 37-897075, Exp 05/11/2023

Recall Number: D-0738-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
3999 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
diphenhydrAMINE 50 mg added to 0.9% sodium chloride 50 mL in 100 mL Partial Additive Bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7090-1.

Batch or Lot Expiration Information

Lot# 37-884155, Exp 05/03/2023; 37-885992, Exp 05/10/2023; 37-887348, Exp 05/16/2023; 37-887660, Exp 05/17/2023; 37-889052, Exp 05/23/2023; 37-891155, 37-891156, Exp 05/31/2023; 37-891443, Exp 06/01/2023; 37-892475, Exp 06/06/2023

Recall Number: D-0694-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
128 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 6%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0423-1.

Batch or Lot Expiration Information

Lot# 37-896152, Exp 05/06/2023; 37-897923, Exp 05/13/2023; 37-899173, Exp 05/19/2023

Recall Number: D-0665-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
48 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Induction 8:1 High Potassium/low dextrose, 100 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0107-1.

Batch or Lot Expiration Information

Lot# 37-897926, Exp 05/13/2023; 37-900464, Exp 05/22/2023

Recall Number: D-0656-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
144 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Microplegia Solution, MSA/MSG 0.92 Molar with CP2D, packaged in 120 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0012-2.

Batch or Lot Expiration Information

Lot# 37-893787, Exp 04/28/2023; 37-895645, Exp 05/05/2023; 37-897071, Exp 05/11/2023; 37-897802, Exp 05/12/2023; 37-899136, Exp 05/19/2023

Recall Number: D-0717-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
4390 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vancomycin added to 0.9% sodium chloride, 1 g/250 mL* (4 mg/mL), 25 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6064-1.

Batch or Lot Expiration Information

Lot# 37-885351, Exp 05/08/2023; 37-885979, Exp 05/10/2023; 37-887721, Exp 05/17/2023; 37-889212, Exp 05/23/2023; 37-889607, Exp 05/24/2023; 37-891247, Exp 05/31/2023; 37-892937, Exp 06/07/2023; 37-894025, Exp 06/12/2023; 37-894748, Exp 06/14/2023; 37-895282, Exp 06/18/2023; 37-896173, Exp 06/20/2023

Recall Number: D-0672-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
333 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Induction 4:1 in Ringer's, HIGH POTASSIUM, 48 mEq K, packaged in 522.8 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0206-1.

Batch or Lot Expiration Information

Lot# 37-894326, Exp 04/29/2023; 37-895212, Exp 05/04/2023; 37-896794, Exp 05/08/2023; 37-897286, Exp 05/12/2023; 37-899267, Exp 05/19/2023

Recall Number: D-0673-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
329 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Modified St Thomas Formula, HIGH POTASSIUM, 122 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0209-1.

Batch or Lot Expiration Information

Lot# 37-893789, Exp 04/28/2023; 37-894318, Exp 04/29/2023; 37-895648, Exp 05/05/2023; 37-897301, Exp 05/12/2023; 37-898815, Exp 05/18/2023

Recall Number: D-0654-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
254 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Reperfusate 4:1 low potassium/low tromethamine, 15 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0009-1.

Batch or Lot Expiration Information

Lot# 37-893848, Exp 04/28/2023; 37-895681, Exp 05/05/2023; 37-899250, Exp 05/19/2023; 37-901355, Exp 05/27/2023

Recall Number: D-0649-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
215 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Warm Induction 4:1 High Potassium (40 mEq) packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0002-1.

Batch or Lot Expiration Information

Lot# 37-893802, Exp 04/28/2023; 37-894943, Exp 05/01/2023; 37-896487, Exp 05/07/2023; 37-898248, Exp 05/14/2023; 37-899171, Exp 05/19/2023

Recall Number: D-0705-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
560 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 15 units added to Lactated Ringer's 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6037-1.

Batch or Lot Expiration Information

Lot# 37-891282, Exp 05/06/2023; 37-900124, Exp 06/10/2023

Recall Number: D-0661-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
269 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Maintenance 4:1 low potassium, 20 mEq K, packaged in 810 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0103-1.

Batch or Lot Expiration Information

Lot# 37-893803, Exp 04/28/2023; 37-896483, Exp 05/07/2023; 37-897939, Exp 05/13/2023; 37-900952, Exp 05/26/2023

Recall Number: D-0725-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
11338 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vancomycin added to 0.9% sodium chloride, 1.5 g/500 mL* (3 mg/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6176-1.

Batch or Lot Expiration Information

Lot# 37-883372, 37-883387, Exp 05/01/2023; 37-883790, Exp 05/02/2023; 37-884160, Exp 05/03/2023; 37-885320, 37-885321, 37-885324, Exp 05/08/2023; 37-885921, 37-885928, 37-885930, Exp 05/10/2023; 37-886270, Exp 05/11/2023; 37-887511, Exp 05/16/2023; 37-887666, 37-887670, Exp 05/17/2023; 37-888115, Exp 05/18/2023; 37-888841, Exp 05/22/2023; 37-889457, 37-889462, Exp 05/24/2023; 37-892638, 37-892641, 37-892648, Exp 06/06/2023; 37-892907, Exp 06/07/2023; 37-894437, 37-894443, 37-894450, Exp 06/13/2023; 37-895707, 37-895718, 37-895723, Exp 06/19/2023; 37-896532, 37-896535, Exp 06/21/2023; 37-898527, Exp 06/29/2023

Recall Number: D-0708-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
3865 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 72185-6042-1.

Batch or Lot Expiration Information

Lot# 37-883926, Exp 05/02/2023; 37-886032, Exp 05/10/2023; 37-887681, Exp 05/17/2023; 37-888317, Exp 05/21/2023; 37-890906, Exp 05/30/2023; 37-892146, Exp 06/05/2023; 37-892507, Exp 06/06/2023; 37-894483, Exp 06/13/2023; 37-896595, Exp 06/21/2023; 37-898568, Exp 06/29/2023

Recall Number: D-0700-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
175 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4.5%/Dextrose 10% with HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0432-1.

Batch or Lot Expiration Information

Lot# 37-894962, Exp 05/01/2023; 37-898285, Exp 05/14/2023

Recall Number: D-0691-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
877 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0420-1.

Batch or Lot Expiration Information

Lot# 37-894314, Exp 04/29/2023; 37-894690, 37-894699, Exp 04/30/2023; 37-895627, Exp 05/05/2023; 37-896494, Exp 05/07/2023; 37-897082, Exp 05/11/2023; 37-897955, Exp 05/13/2023; 37-899254, Exp 05/19/2023; 37-900057, 37-900060, Exp 05/21/2023

Recall Number: D-0740-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
2186 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 40 units added to 0.9% sodium chloride 1,000 bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8069-1.

Batch or Lot Expiration Information

Lot# 37-886265, Exp 05/11/2023; 37-886266, Exp 05/11/2023; 37-889903, Exp 05/25/2023; 37-890551, Exp 05/29/2023; 37-892521, 37-892620, Exp 06/06/2023; 37-896246, 37-896247, Exp 06/20/2023; 37-898553, Exp 06/29/2023

Recall Number: D-0651-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
151 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Reperfusate No Potassium, packaged in 477.5 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0006-1.

Batch or Lot Expiration Information

Lot# 37-895691, Exp 05/05/2023; 37-896792, Exp 05/08/2023; 37-899170, Exp 05/19/2023

Recall Number: D-0662-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
476 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Maintenance 4:1 low potassium/low tromethamine, 36 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0104-1.

Batch or Lot Expiration Information

Lot# 37-893850, Exp 04/28/2023; 37-894947, Exp 05/01/2023; 37-895695, Exp 05/05/2023; 37-896484, Exp 05/07/2023; 37-898314, Exp 05/14/2023; 37-898811, Exp 05/18/2023; 37-900616, Exp 05/25/2023

Recall Number: D-0707-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
21871 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 30 units added to Lactated Ringer's 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6039-1.

Batch or Lot Expiration Information

Lot# 37-889853, 37-889854, 37-889856, Exp 04/30/2023; 37-890087, 37-890088, 37-890095, 37-890098, 37-890100, 37-890107, 37-890109, Exp 05/03/2023; 37-890876, 37-890878, 37-890885, 37-890891, Exp 05/05/2023; 37-891572, Exp 05/07/2023; 37-892504, 37-892510, 37-892512, 37-892520, 37-892560, 37-892575, 37-892585, 37-892587, Exp 05/12/2023; 37-892988, 37-892989, Exp 05/13/2023; 37-894323, 37-894356, 37-894366, 37-894385, 37-894386, 37-894402, 37-894409, 37-894410, Exp 05/19/2023; 37-894778, Exp 05/20/2023; 37-894998, 37-894999, 37-895000, 37-895001, 37-895002, Exp 05/21/2023; 37-896186, 37-896189, 37-896192, 37-896194, 37-896200, 37-896202, 37-896227, 37-896231, 37-896240, 37-896241, Exp 05/26/2023; 37-896844, 37-896851, 37-896853, 37-896856, Exp 05/28/2023; 37-897827, 37-897836, 37-897837, 37-897853, 37-897854, 37-897928, Exp 06/02/2023; 37-900117, 37-900122, 37-900123, Exp 06/10/2023

Recall Number: D-0734-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
6341 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
NORepinephrine added to 0.9% sodium chloride, 16 mg/250 mL* (64 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7036-1.

Batch or Lot Expiration Information

Lot# 37-882998, 37-883005, 37-883145, Exp 04/28/2023; 37-883144, 37-883220, 37-883221, 37-883222, Exp 04/30/2023; 37-883925, Exp 05/02/2023; 37-884180, 37-884181, Exp 05/03/2023; 37-884505, 37-884506, 37-884507, 37-884508, 37-884509, Exp 05/04/2023; 37-884834, 37-884869, 37-884870, Exp 05/07/2023; 37-886058, Exp 05/10/2023; 37-886536, 37-886537, Exp 05/14/2023; 37-887062, 37-887389, Exp 05/15/2023; 37-887784, 37-887787, Exp 05/17/2023; 37-888029, 37-888048, Exp 05/18/2023; 37-888261, 37-888263, 37-888269, 37-888282, 37-888292, 37-888294, 37-888301, 37-888302, Exp 05/21/2023; 37-890058, 37-890064, 37-890074, 37-890076, Exp 05/28/2023; 37-891747, 37-891748, 37-891750, 37-891751, 37-891753, Exp 06/04/2023; 37-893530, 37-893531, 37-893532, Exp 06/11/2023; 37-894760, 37-894761, Exp 06/14/2023; 37-894988, 37-894990, Exp 06/15/2023; 37-896260, Exp 06/20/2023; 37-896621, Exp 06/21/2023; 37-898518, 37-898519, Exp 06/29/2023; 37-898789, 37-898790, 37-898791, 37-898792, 37-898793, Exp 07/02/2023; 37-899718, Exp 07/04/2023; 37-900591, 37-900596, Exp 07/09/2023; 37-901149, Exp 07/10/2023

Recall Number: D-0677-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
79 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Microplegia Solution, HIGH POTASSIUM (100 mEq), packaged in 200 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0213-1.

Batch or Lot Expiration Information

Lot# 37-895226, Exp 05/04/2023; 37-900615, Exp 05/25/2023

Recall Number: D-0718-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
3075 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vancomycin added to 0.9% sodium chloride, 750 mg/250 mL* (3 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6071-1.

Batch or Lot Expiration Information

Lot# 37-884161, Exp 05/03/2023; 37-885995, 37-885997, Exp 05/10/2023; 37-887729, Exp 05/17/2023; 37-889595, Exp 05/24/2023; 37-891272, Exp 05/31/2023; 37-892162, Exp 06/05/2023; 37-894716, Exp 06/14/2023

Recall Number: D-0745-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
4994 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
NORepinephrine added to 0.9% sodium chloride, 4 mg/250 mL* (16 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8097-1.

Batch or Lot Expiration Information

Lot# 37-884510, Exp 05/04/2023; 37-885671, Exp 05/09/2023; 37-886285, Exp 05/11/2023; 37-888322, Exp 05/21/2023; 37-888851, Exp 05/22/2023; 37-889840, Exp 05/25/2023; 37-890130, Exp 05/28/2023; 37-890966, Exp 05/30/2023; 37-893529, Exp 06/11/2023; 37-894766, Exp 06/14/2023; 37-895300, 37-895301, Exp 06/18/2023; 37-898521, Exp 06/29/2023; 37-900338, Exp 07/06/2023

Recall Number: D-0652-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
140 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Reperfusate 4:1 low potassium, 7.5 mEq K, packaged in 238.75 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0007-1.

Batch or Lot Expiration Information

Lot# 37-896489, Exp 05/07/2023; 37-897805, Exp 05/12/2023; 37-900959, Exp 05/26/2023

Recall Number: D-0669-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
182 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Modified St Thomas Solution, low potassium, HIGH SODIUM BICARBONATE, 62 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0203-1.

Batch or Lot Expiration Information

Lot# 37-894704, Exp 04/30/2023; 37-896126, Exp 05/06/2023; 37-898276, Exp 05/14/2023; 37-899141, Exp 05/19/2023

Recall Number: D-0728-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
2146 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
potassium phosphate 30 mmole added to 0.9% sodium chloride 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7016-1.

Batch or Lot Expiration Information

Lot# 37-883219, Exp 04/30/2023; 37-885926, Exp 05/10/2023; 37-887382, Exp 05/16/2023; 37-889455, Exp 05/24/2023; 37-890060, Exp 05/28/2023; 37-893444, Exp 06/11/2023; 37-894987, Exp 06/15/2023

Recall Number: D-0722-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
9037 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vancomycin added to 0.9% sodium chloride, 1.5 g/250 mL* (6 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6076-1.

Batch or Lot Expiration Information

Lot# 37-883390, 37-883435, Exp 05/01/2023; 37-884157, Exp 05/03/2023; 37-885716, 37-886036, 37-886039, Exp 05/09/2023; 37-887499, 37-887500, Exp 05/16/2023; 37-887778, Exp 05/17/2023; 37-888105, Exp 05/18/2023; 37-889216, Exp 05/23/2023; 37-890923, 37-890928, 37-890936, Exp 05/30/2023; 37-891271, Exp 05/31/2023; 37-892649, Exp 06/06/2023; 37-892962, Exp 06/07/2023; 37-893966, 37-893967, 37-893969, 37-893998, Exp 06/12/2023; 37-896160, 37-896162, 37-896171, Exp 06/20/2023

Recall Number: D-0729-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
5627 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
EPINEPHrine added to dextrose 5%, 4 mg/250 mL* (16 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7018-1.

Batch or Lot Expiration Information

Lot# 37-883218, Exp 04/30/2023; 37-885235, Exp 05/08/2023; 37-885923, Exp 05/10/2023; 37-889050, Exp 05/23/2023; 37-890053, 37-890054, Exp 05/28/2023; 37-891439, 37-891441, Exp 06/01/2023; 37-892500, Exp 06/06/2023; 37-894308, Exp 06/13/2023; 37-896125, Exp 06/20/2023; 37-896926, Exp 06/22/2023; 37-900396, Exp 07/06/2023

Recall Number: D-0748-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
100 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vasopressin 40 units added to 0.9% sodium chloride 100 mL*, 0.4 units/mL*, 100 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-9001-1.

Batch or Lot Expiration Information

Lot# 37-889738, 37-889742, Exp 05/25/2023

Recall Number: D-0754-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
554 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
HyperLyte CR Injection, 500 mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8094-1, code 7128580941.

Batch or Lot Expiration Information

Lot# 37-874236, Exp 06/20/2023; 37-878694, Exp 07/10/2023

Recall Number: D-0701-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
3338 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
EPINEPHrine added to dextrose 5%, 2 mg/250 mL* (8 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6030-1.

Batch or Lot Expiration Information

Lot# 37-884448, Exp 05/04/2023; 37-887386, Exp 05/16/2023; 37-888271, Exp 05/21/2023; 37-891189, Exp 05/31/2023; 37-893456, Exp 06/11/2023; 37-894656, Exp 06/14/2023; 37-898333, Exp 06/28/2023; 37-898559, Exp 06/29/2023

Recall Number: D-0670-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
241 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Modified St Thomas Solution, HIGH POTASSIUM, HIGH SODIUM BICARBONATE, 106 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0204-1.

Batch or Lot Expiration Information

Lot# 37-894705, Exp 04/30/2023; 37-896127, Exp 05/06/2023; 37-898278, Exp 05/14/2023; 37-899148, Exp 05/19/2023; 37-900619, Exp 05/25/2023

Recall Number: D-0699-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
60 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 6%/Dextrose 10% with low calcium and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0430-1.

Batch or Lot Expiration Information

Lot# 37-896506, Exp 05/07/2023; 37-898306, Exp 05/14/2023; 37-900062, Exp 05/21/2023

Recall Number: D-0689-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
92 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2.5%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0418-1.

Batch or Lot Expiration Information

Lot# 37-894334, Exp 04/29/2023; 37-898299, Exp 05/14/2023

Recall Number: D-0695-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
135 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2%/Dextrose 10% with low calcium and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0425-1.

Batch or Lot Expiration Information

Lot# 37-894712, Exp 04/30/2023; 37-897924, Exp 05/13/2023; 37-899606, Exp 05/20/2023

Recall Number: D-0716-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
9432 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
potassium phosphate 15 mmole added to 0.9% sodium chloride 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6060-1.

Batch or Lot Expiration Information

Lot# 37-883769, Exp 05/02/2023; 37-884449, Exp 05/04/2023; 37-885585, Exp 05/09/2023; 37-885922, Exp 05/10/2023; 37-886526, Exp 05/14/2023; 37-887387, Exp 05/16/2023; 37-887659, 37-887662, Exp 05/17/2023; 37-889064, Exp 05/23/2023; 37-889735, 37-889745, Exp 05/25/2023; 37-890036, 37-890055, Exp 05/28/2023; 37-890934, Exp 05/30/2023; 37-892890, Exp 06/07/2023; 37-893813, Exp 06/12/2023; 37-894317, Exp 06/13/2023; 37-895275, Exp 06/18/2023; 37-896822, 37-896852, Exp 06/22/2023; 37-897826, 37-897839, Exp 06/27/2023

Recall Number: D-0685-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
138 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10% with CALCIUM, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0407-1.

Batch or Lot Expiration Information

Lot# 37-894709, Exp 04/30/2023; 37-896128, Exp 05/06/2023; 37-897894, Exp 05/13/2023

Recall Number: D-0650-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
255 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Reperfusate No Potassium, packaged in 238.75 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0005-1.

Batch or Lot Expiration Information

Lot# 37-893790, Exp 04/28/2023; 37-896488, Exp 05/07/2023; 37-898250, Exp 05/14/2023; 37-899235, Exp 05/19/2023; 37-900609, Exp 05/25/2023

Recall Number: D-0698-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
328 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal PN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10% with low calcium and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100 Allentown, PA 18106, NDC 71285-0429-1.

Batch or Lot Expiration Information

Lot# 37-894695, Exp 04/30/2023; 37-895693, Exp 05/05/2023; 37-900065, Exp 05/21/2023; 37-900622, Exp 05/25/2023

Recall Number: D-0713-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
3040 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
dilTIAZem added to 0.9% sodium chloride, 125 mg/125 mL* (1 mg/mL), 125 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6055-1.

Batch or Lot Expiration Information

Lot# 37-896374, 37-896375, Exp 05/31/2023; 37-896876, 37-896878, Exp 06/02/2023; 37-897077, 37-897078, Exp 06/05/2023; 37-900074, 37-900075, 37-900076, 37-900111, 37-900112, 37-900115, Exp 06/15/2023; 37-900328, Exp 06/16/2023

Recall Number: D-0733-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
13953 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
PHENYLephrine added to 0.9% sodium chloride, 20 mg/250 mL* (80 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7025-1.

Batch or Lot Expiration Information

Lot# 37-883074, Exp 04/28/2023; 37-883237, 37-883238, Exp 04/30/2023; 37-883940, Exp 05/02/2023; 37-884271, Exp 05/03/2023; 37-884749, 37-884751, Exp 05/05/2023; 37-885338, Exp 05/08/2023; 37-885756, Exp 05/09/2023; 37-886272, Exp 05/11/2023; 37-887512, Exp 05/16/2023; 37-888027, 37-888030, 37-888040, 37-888052, 37-888063, Exp 05/18/2023; 37-888314, Exp 05/21/2023; 37-890489, 37-890497, 37-890534, Exp 05/29/2023; 37-890933, Exp 05/30/2023; 37-891152, Exp 05/31/2023; 37-892985, 37-892986, 37-892995, Exp 06/07/2023; 37-893511, 37-893517, Exp 06/11/2023; 37-896481, Exp 06/21/2023; 37-897828, Exp 06/27/2023; 37-898523, Exp 06/29/2023

Recall Number: D-0684-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
71 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10%, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0406-1.

Batch or Lot Expiration Information

Lot# 37-894328, Exp 04/29/2023; 37-897792, Exp 05/12/2023

Recall Number: D-0743-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
2890 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
NORepinephrine added to dextrose 5%, 16 mg/250 mL* (64 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8095-1.

Batch or Lot Expiration Information

Lot# 37-883007, 37-883015, 37-883017, Exp 04/28/2023; 37-883236, Exp 04/30/2023; 37-884187, 37-884189, 37-884190, Exp 05/03/2023; 37-884567, 37-884568, 37-884569, Exp 05/04/2023; 37-887789, 37-887790, Exp 05/17/2023; 37-889142, 37-889143, 37-889144, 37-889149, Exp 05/23/2023; 37-889606, Exp 05/24/2023; 37-890519, 37-890528, Exp 05/29/2023; 37-890946, 37-890951, Exp 05/30/2023; 37-891281, 37-891284, 37-891292, 37-891294, Exp 05/31/2023; 37-891756, 37-891757, Exp 06/04/2023; 37-897959, 37-897961, Exp 06/27/2023; 37-898795, Exp 07/02/2023

Recall Number: D-0671-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
280 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Maintenance 4:1 in Ringer's, low potassium, 12 mEq K, packaged in 504.8 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0205-1.

Batch or Lot Expiration Information

Lot# 37-894325, Exp 04/29/2023; 37-895211, Exp 05/04/2023; 37-899265, Exp 05/19/2023

Recall Number: D-0742-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
8171 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
EPINEPHrine added to 0.9% sodium chloride, 4 mg/250 mL* (16 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8093-1.

Batch or Lot Expiration Information

Lot# 37-882988, Exp 04/28/2023; 37-883194, 37-883208, Exp 04/30/2023; 37-884746, Exp 05/05/2023; 37-885215, Exp 05/08/2023; 37-885927, Exp 05/10/2023; 37-887044, 37-887051, Exp 05/15/2023; 37-887667, Exp 05/17/2023; 37-888297, 37-888298, Exp 05/21/2023; 37-890886, Exp 05/30/2023; 37-891438, Exp 06/01/2023; 37-892497, Exp 06/06/2023; 37-893159, Exp 06/08/2023; 37-893843, Exp 06/12/2023; 37-894649, Exp 06/14/2023; 37-896928, Exp 06/22/2023; 37-899304, Exp 07/03/2023

Recall Number: D-0714-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
2041 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
norepinephrine 4 mg added to dextrose 5% 250 mL*, 16 mcg/mL, 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6056-1.

Batch or Lot Expiration Information

Lot# 37-884760, Exp 05/05/2023; 37-885601, Exp 05/09/2023; 37-887668, Exp 05/17/2023; 37-889594, Exp 05/24/2023; 37-892622, Exp 06/06/2023; 37-894316, Exp 06/13/2023

Recall Number: D-0702-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
7595 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 20 units added to dextrose 5%/Lactated Ringer's 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6031-1.

Batch or Lot Expiration Information

Lot# 37-883206, 37-883207, 37-883210, 37-883213, 37-883216, 37-883217, 37-883217, Exp 04/30/2023; 37-884447, 37-884450, Exp 05/04/2023; 37-886269, Exp 05/11/2023; 37-887516, Exp 05/16/2023; 37-888306, 37-888308, 37-888310, 37-888311, Exp 05/21/2023; 37-890097, 37-890099, 37-890101, 37-890108, Exp 05/28/2023; 37-892636, 37-892637, 37-892639, 37-892640, Exp 06/06/2023; 37-894451, 37-894452, 37-894476, 37-894482, Exp 06/13/2023; 37-895311, 37-895312, 37-895313, Exp 06/18/2023; 37-895804, Exp 06/19/2023; 37-896607, Exp 06/21/2023

Recall Number: D-0674-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
208 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Modified St Thomas Formula, low potassium, 70 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0210-1.

Batch or Lot Expiration Information

Lot# 37-894320, Exp 04/29/2023; 37-894324, Exp 04/29/2023; 37-897297, Exp 05/12/2023; 37-898509, Exp 05/15/2023

Recall Number: D-0721-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
10282 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vancomycin added to dextrose 5%, 1.5 g/250 mL* (6 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6075-1.

Batch or Lot Expiration Information

Lot# 37-883196, 37-883197, 37-883205, Exp 04/30/2023; 37-884882, 37-884890, 37-884898, Exp 05/07/2023; 37-886840, 37-886858, 37-886863, Exp 05/15/2023; 37-887365, Exp 05/16/2023; 37-887663, Exp 05/17/2023; 37-888254, 37-888257, 37-888265, 37-888303, Exp 05/21/2023; 37-889453, Exp 05/24/2023; 37-890037, 37-890039, 37-890043, Exp 05/28/2023; 37-890330, 37-890333, 37-890344, Exp 05/29/2023; 37-892009, 37-892011, 37-892016, Exp 06/05/2023; 37-892881, Exp 06/07/2023; 37-893448, Exp 06/11/2023; 37-895221, Exp 06/18/2023; 37-898530, Exp 06/29/2023

Recall Number: D-0687-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
258 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 5% with CALCIUM, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0413-1.

Batch or Lot Expiration Information

Lot# 37-894313, Exp 04/29/2023; 37-895257, Exp 05/04/2023; 37-897360, Exp 05/12/2023; 37-897890, Exp 05/13/2023; 37-900964, Exp 05/26/2023

Recall Number: D-0709-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
5544 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 20 units added to 0.9% sodium chloride 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 72185-6043-1.

Batch or Lot Expiration Information

Lot# 37-883938, Exp 05/02/2023; 37-884910, 37-884915, Exp 05/07/2023; 37-886041, Exp 05/10/2023; 37-887515, 37-887520, Exp 05/16/2023; 37-888318, Exp 05/21/2023; 37-888847, Exp 05/22/2023; 37-890535, Exp 05/29/2023; 37-890957, Exp 05/30/2023; 37-891566, 37-891568, Exp 06/01/2023; 37-892156, Exp 06/05/2023; 37-893165, 37-893166, Exp 06/08/2023; 37-893994, 37-893995, Exp 06/12/2023; 37-895771, 37-895773, 37-895775, Exp 06/19/2023; 37-896614, Exp 06/21/2023; 37-900377, Exp 07/06/2023

Recall Number: D-0706-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
14362 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 20 units added to Lactated Ringer's 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6038-1.

Batch or Lot Expiration Information

Lot# 37-889158, 37-889187, 37-889189, Exp 04/28/2023; 37-889494, 37-889507, 37-889522, 37-889525, 37-889527, 37-889608, Exp 04/29/2023; 37-889906, 37-889912, 37-889913, Exp 04/30/2023; 37-890110, 37-890121, Exp 05/03/2023; 37-891160, 37-891162, 37-891186, 37-891188, 37-891199, 37-891211, Exp 05/06/2023; 37-891564, 37-891565, 37-891567, 37-891569, 37-891570, Exp 05/07/2023; 37-892591, Exp 05/12/2023; 37-892893, 37-892897, 37-892900, 37-892902, 37-892903, 37-892904, 37-892909, 37-892910, Exp 05/13/2023; 37-894715, 37-894720, 37-894749, 37-894754, 37-894762, 37-894763, 37-894765, Exp 05/20/2023; 37-894991, 37-894992, 37-894993, Exp 05/21/2023; 37-896187, 37-896188, 37-896190, 37-896191, 37-896199, 05/26/2023; 37-896521, 37-896522, 37-896523, Exp 05/27/2023; 37-896883, 37-896884, Exp 05/28/2023; 37-900067, 37-900068, Exp 06/10/2023

Recall Number: D-0710-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
104807 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6044-1.

Batch or Lot Expiration Information

Lot# 37-883041, 37-883043, 37-883044, 37-883045, 37-883047, 37-883059, 37-883060, 37-883067, 37-883071, 37-883072, 37-883131, 37-883185, Exp 04/28/2023; 37-883492, 37-883499, 37-883501, 37-883503, 37-883514, 37-883525, 37-883526, 37-883539, 37-883540, 37-883548, 37-883549, 37-883550, 37-883551, Exp 05/01/2023; 37-884229, 37-884230, 37-884245, 37-884249, 37-884252, 37-884256, 37-884260, 37-884261, 37-884262, 37-884266, 37-884270, Exp 05/03/2023; 37-884452, 37-884453, 37-884457, 37-884461, 37-884464, 37-884466, 37-884468, 37-884470, 37-884472, 37-884473, Exp 05/04/2023; 37-884793, 37-884812, 37-884817, 37-884821, 37-884822, 37-884830, 37-884833, 37-884874, 37-884881, 37-884886, 37-884895, 37-884905, 37-884907, 37-884916, 37-884917, Exp 05/05/2023; 37-884807, 37-884941, 37-884942, 37-884943, 37-884944, 37-884945, 37-884946, 37-884954, 37-884955, 37-884956, Exp 05/07/2023; 37-885187, 37-885217, 37-885244, 37-885247, 37-885261, 37-885268, 37-885279, 37-885282, 37-885291, 37-885293, Exp 05/08/2023; 37-885584, 37-885598, 37-885608, Exp 05/09/2023; 37-886056, 37-886057, 37-886060, 37-886081, 37-886082, 37-886088, 37-886089, Exp 05/10/2023; 37-886251, 37-886256, 37-886257, 37-886259, 37-886263, 37-886264, Exp 05/11/2023; 37-886499, 37-886503, 37-886510, 37-886527, 37-886530, 37-886532, 37-886534, 37-886538, 37-886541, 37-886542, 37-886543, Exp 05/14/2023; 37-887304, 37-887306, 37-887307, 37-887308, 37-887309, 37-887310, 37-887311, 37-887312, Exp 05/16/2023; 37-887672, 37-887693, 37-887718, 37-887724, 37-887728, 37-887753, Exp 05/17/2023; 37-888081, 37-888082, 37-888084, 37-888086, Exp 05/18/2023; 37-888304, 37-888305, 37-888307, 37-888309, 37-888312, 37-888313, 37-888315, 37-888316, Exp 05/21/2023; 37-888695, 37-888705, 37-888722, 37-888742, 37-888764, Exp 05/22/2023; 37-889048, 37-889049, 37-889061, 37-889065, 37-889118, 37-889133, 37-889139, Exp 05/23/2023; 37-889530, 37-889534, 37-889541, 37-889561, 37-889562, 37-889563, 37-889571, 37-889573, 37-889703, Exp 05/24/2023; 37-889733, 37-889747, 37-889793, 37-889803, 37-889828, 37-889829, 37-889839, 37-889841, 37-889847, 37-889851, Exp 05/25/2023; 37-890413, 37-890419, 37-890427, 37-890430, 37-890435, 37-890443, 37-890444, 37-890473, Exp 05/29/2023; 37-890958, Exp 05/30/2023; 37-891217, 37-891221, 37-891224, 37-891229, 37-891231, 37-891233, 37-891248, Exp 05/31/2023; 37-891475, 37-891479, 37-891481, 37-891484, 37-891486, 37-891488, 37-891531, 37-891549, 37-891550, 37-891562, Exp 06/01/2023; 37-892164, 37-892183, 37-892195, Exp 06/05/2023; 37-892878, 37-892883, 37-892885, 37-892891, 37-892892, 37-892895, 37-892896, Exp 06/07/2023; 37-893167, 37-893168, 37-893200, 37-893203, 37-893205, 37-893206, 37-893219, Exp 06/08/2023; 37-893457, 37-893462, 37-893468, Exp 06/11/2023; 37-893798, 37-893799, 37-893808, 37-893809, 37-893814, 37-893844, Exp 06/12/2023; 37-894655, 37-894661, 37-894664, 37-894666, 37-894686, 37-894703, Exp 06/14/2023; 37-895029, 37-895030, 37-895036, 37-895037, 37-895038, 37-895048, 37-895056, 37-895063, 37-895068, 37-895072, 37-895073, 37-895074, 37-895075, Exp 06/15/2023; 37-895260, 37-895271, 37-895273, 37-895274, Exp 06/18/2023; 37-895623, 37-895624, 37-895644, 37-895653, 37-895661, 37-895676, 37-895677, 37-895678, 37-895679, 37-895774, 37-895776, Exp 06/19/2023; 37-896536, 37-896540, 37-896541, 37-896542, 37-896543, 37-896547, 37-896566, 37-896585, 37-896587, 37-896596, 37-896597, 37-896598, 37-896599, 37-896615, Exp 06/21/2023; 37-896864, 37-896868, 37-896870, 37-896877, 37-896879, 37-896882, 37-896882, 37-896885, 37-896899, 37-896901, 37-896903, 37-896914, 37-896915, 37-896916, Exp 06/22/2023; 37-897454, 37-897500, Exp 06/26/2023; 37-898273, Exp 06/28/2023; 37-898517, Exp 06/29/2023

Recall Number: D-0682-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
80 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2%/Dextrose 10%, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0400-1.

Batch or Lot Expiration Information

Lot# 37-895214, Exp 05/04/2023; 37-897950, Exp 05/13/2023; 37-899603, Exp 05/20/2023

Recall Number: D-0703-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
2624 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 30 units added to dextrose 5%/Lactated Ringer's 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6032-1.

Batch or Lot Expiration Information

Lot# 37-883948, Exp 05/02/2023; 37-886037, 37-886040, Exp 05/10/2023; 37-889593, Exp 05/24/2023; 37-891270, Exp 05/31/2023; 37-893223, Exp 06/08/2023; 37-896230, Exp 06/20/2023; 37-898520, Exp 06/29/2023

Recall Number: D-0712-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
1230 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
dilTIAZem added to dextrose 5%, 125 mg/125 mL* (1 mg/mL), 125 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 72185-6054-1.

Batch or Lot Expiration Information

Lot# 37-896365, 37-896367, 37-896370, Exp 05/31/2023; 37-896857, 37-896858, 37-896859, Exp 06/02/2023

Recall Number: D-0752-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
3326 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Potassium Acetate Injection, 2 mEq/mL, 500 ml bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8078-1, code 7128580781.

Batch or Lot Expiration Information

Lot# 37-884108, 37-884109, Exp 05/03/2023; 37-884957, Exp 05/07/2023; 37-885047, 37-885048, Exp 05/08/2023; 37-885919, Exp 05/10/2023; 37-889426, 37-889432, Exp 05/24/2023; 37-891933, Exp 06/05/2023; 37-894274, Exp 06/13/2023; 37-896048, 37-896049, Exp 06/20/2023; 37-897798, Exp 06/27/2023

Recall Number: D-0747-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
1858 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vasopressin 20 units added to 0.9% sodium chloride 100 mL*, 0.2 units/mL*, 100 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-9000-1.

Batch or Lot Expiration Information

Lot# 37-886252, 37-886254, Exp 05/11/2023; 37-889741, 37-889746, Exp 05/25/2023; 37-891444, Exp 06/01/2023; 37-893155, 37-893156, Exp 06/08/2023; 37-896812, Exp 06/22/2023

Recall Number: D-0667-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
476 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Maintenance 4:1 Plasma-Lyte/Tromethamine, low potassium, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0112-1.

Batch or Lot Expiration Information

Lot# 37-894300, Exp 04/29/2023; 37-896114, Exp 05/06/2023; 37-896417, Exp 05/07/2023; 37-897388, Exp 05/12/2023; 37-898798, Exp 05/18/2023; 37-899618, Exp 05/20/2023

Recall Number: D-0746-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
2992 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
heparin added to 0.9% sodium chloride, 2,500 units/500 mL* (5 units/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8100-1.

Batch or Lot Expiration Information

Lot# 37-888833, Exp 05/02/2023; 37-890537, Exp 05/09/2023; 37-892161, 37-892163, Exp 05/16/2023; 37-893979, 37-893992, Exp 05/23/2023; 37-895755, 37-895758, Exp 05/30/2023

Recall Number: D-0664-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
84 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Induction 4:1 High Potassium, 30 mEq K, packaged in 415 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0106-1.

Batch or Lot Expiration Information

Lot# 37-894307, Exp 04/29/2023; 37-896158, Exp 05/06/2023; 37-898281, Exp 05/14/2023; 37-900321, Exp 05/22/2023

Recall Number: D-0648-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
307 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Microplegia (MSA/MSG 0.92 Molar) packaged in 125 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0001-1.

Batch or Lot Expiration Information

Lot# 37-894942, Exp 05/01/2023; 37-896485, Exp 05/07/2023; 37-896793, Exp 05/08/2023; 37-898247, Exp 05/14/2023; 37-899149, Exp 05/19/2023; 37-900610, Exp 05/25/2023

Recall Number: D-0744-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
6414 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
NORepinephrine added to 0.9% sodium chloride, 8 mg/250 mL* (32 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8096-1.

Batch or Lot Expiration Information

Lot# 37-882989, Exp 04/28/2023; 37-883827, 37-883829, 37-883830, 37-883833, 37-883858, Exp 05/02/2023; 37-884758, Exp 05/05/2023; 37-885357, Exp 05/08/2023; 37-885748, 37-885751, Exp 05/09/2023; 37-887409, 37-887410, Exp 05/16/2023; 37-888863, 37-888867, Exp 05/22/2023; 37-889226, Exp 05/23/2023; 37-889576, 37-889577, Exp 05/24/2023; 37-889804, 37-889817, 37-889830, Exp 05/25/2023; 37-891280, Exp 05/31/2023; 37-891758, 37-891759, Exp 06/04/2023; 37-894311, 37-894315, 37-894319, Exp 06/13/2023; 37-895304, Exp 06/18/2023; 37-896544, 37-896545, 37-896546, 37-896552, Exp 06/21/2023; 37-898514, 37-898515, 37-898516, Exp 06/29/2023; 37-899305, Exp 07/03/2023; 37-900362, Exp 07/06/2023

Recall Number: D-0688-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
139 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0416-1.

Batch or Lot Expiration Information

Lot# 37-897800, Exp 05/12/2023; 37-897895, Exp 05/13/2023

Recall Number: D-0737-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
5627 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
diphenhydrAMINE 25 mg added to 0.9% sodium chloride 50 mL in 100 mL Partial Additive Bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7089-1.

Batch or Lot Expiration Information

Lot# 37-884145, 37-884154, Exp 05/03/2023; 37-885931, Exp 05/10/2023; 37-888293, Exp 05/21/2023; 37-889057, 37-889063, Exp 05/23/2023; 37-891437, Exp 06/01/2023; 37-893455, Exp 06/11/2023; 37-893788, Exp 06/12/2023; 37-894302, Exp 06/13/2023; 37-894652, Exp 06/14/2023; 37-896817, Exp 06/22/2023; 37-897263, Exp 06/26/2023

Recall Number: D-0736-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
8252 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vancomycin added to 0.9% sodium chloride, 1.75 g/500 mL* (3.5 mg/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7060-1.

Batch or Lot Expiration Information

Lot# 37-884152, 37-884158, Exp 05/03/2023; 37-885300, 37-885302, 37-885307, Exp 05/08/2023; 37-887418, 37-887431, 37-887432, Exp 05/16/2023; 37-888850, 37-888852, 37-888853, Exp 05/22/2023; 37-889188, Exp 05/23/2023; 37-890892, 37-890894, 37-890897, Exp 05/30/2023; 37-891232, Exp 05/31/2023; 37-892014, 37-892017, Exp 06/05/2023; 37-894411, 37-894412, 37-894414, Exp 06/13/2023; 37-894659, Exp 06/14/2023; 37-896078, 37-896089, 37-896097, Exp 06/20/2023; 37-897369, Exp 06/26/2023

Recall Number: D-0659-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
350 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Induction 4:1, HIGH POTASSIUM/low tromethamine, 36 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-0101-1.

Batch or Lot Expiration Information

Lot# 37-895647, Exp 05/05/2023; 37-898310, Exp 05/14/2023; 37-899622, Exp 05/20/2023; 37-900951, Exp 05/26/2023

Recall Number: D-0751-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
3165 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Sodium Phosphates Injection 4 mEq/3 mMol/mL, 500 ml bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8077-1, code 7128580771.

Batch or Lot Expiration Information

Lot# 37-883239, 37-883240, Exp 05/01/2023; 37-884419, 37-884423, Exp 05/04/2023; 37-889009, Exp 05/23/2023; 37-890261, 37-890262, Exp 05/29/2023; 37-891250, Exp 05/31/2023; 37-891412, Exp 06/01/2023; 37-895488, Exp 06/19/2023; 37-896456, Exp 06/21/2023; 37-898159, Exp 06/28/2023

Recall Number: D-0668-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
12,888 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, del Nido Formula, packaged in 1,052.8 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0202-1.

Batch or Lot Expiration Information

Lot# 37-890033, 37-890035, Exp 04/28/2023; 37-890518, 37-890527, 37-890536, 37-890538, Exp 04/29/2023; 37-890844, 37-890845, Exp 04/30/2023; 37-891159, 37-891161, 37-891187, 37-891190, 37-891212, 37-891213, 37-891222, 37-891223, Exp 05/01/2023; 37-891432, 37-891433, 37-891434, 37-891435, 37-891440, 37-891442, 37-891445, 37-891446, 37-891447, Exp 05/02/2023; 37-891746, 37-891754, 37-891755, Exp 05/05/2023; 37-892005, 37-892007, Exp 05/06/2023; 37-892502, 37-892503, 37-892505, 37-892517, 37-892518, 37-892519, 37-892538, Exp 05/07/2023; 37-892871, 37-892873, 37-892874, 37-892879, 37-892880, 37-892886, 37-892887, 37-892888, 37-892899, Exp 05/08/2023; 37-893129, 37-893131, 37-893158, 37-893160, 37-893162, 37-893163, 37-893164, Exp 05/09/2023; 37-893681, 37-893689, 37-893698, 37-893760, 37-893761, 37-893762, Exp 05/13/2023; 37-894275, 37-894276, 37-894277, 37-894301, Exp 05/14/2023; 37-894651, 37-894654, 37-894658, 37-894660, 37-894662, 37-894663, Exp 05/15/2023; 37-894948, 37-894967, 37-894970, Exp 05/16/2023; 37-895276, 37-895278, 37-895281, 37-895284, 37-895285, 37-895286, 37-895289, 37-895297, Exp 05/19/2023; 37-895650, 37-895652, Exp 05/20/2023; 37-896051, 37-896052, 37-896054, 37-896055, 37-896057, 37-896058, 37-896455, Exp 05/21/2023; 37-896418, 37-896419, 37-896420, 37-896438, 37-896453, 37-896454, 37-896855, Exp 05/22/2023; 37-896814, 37-896816, 37-896818, 37-896823, 37-896824, 37-896841, 37-896843, 37-896942, Exp 05/23/2023; 37-897417, 37-897429, Exp 05/27/2023; 37-897856, 37-897857, 37-897858, 37-897880, 37-897881, 37-897882, 37-898264, Exp 05/28/2023; 37-898180, 37-898222, 37-898225, 37-898226, 37-898227, 37-898228, Exp 05/29/2023; 37-898487, 37-898488, 37-898490, Exp 05/30/2023; 37-898781, 37-898782, 37-898784, 37-898787, 37-898788, Exp 06/02/2023; 37-899102, 37-899103, 37-899104, 37-899105, Exp 06/03/2023; 37-899590, 37-899598, 37-899599, 37-900116, Exp 06/04/2023; 3700000900051, 37-900052, 37-900054, 37-900055, Exp 06/05/2023; 37-900306, 37-900309, 37-900310, 37-900311, 37-900313, 37-900314, 37-900315, 37-900316, Exp 06/06/2023

Recall Number: D-0750-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
653 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
MSA 7.84% MSG 8.56% (0.92M) Comp. Sol. 1000 ml bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8029-1, code 7128580291.

Batch or Lot Expiration Information

Lot# 37-882955, Exp 04/29/2023; 37-884753, 37-884755, Exp 05/06/2023; 37-887536, 37-887537, Exp 05/17/2023; 37-888532, Exp 05/23/2023; 37-892474, Exp 06/07/2023; 37-896761, Exp 06/23/2023; 37-897261, Exp 06/27/2023

Recall Number: D-0696-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
259 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 5% with low calcium and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0427-1.

Batch or Lot Expiration Information

Lot# 37-894338, Exp 04/29/2023; 37-896505, Exp 05/07/2023; 37-898301, Exp 05/14/2023; 37-898305, Exp 05/14/2023; 37-900061, Exp 05/21/2023

Recall Number: D-0658-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
267 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Induction 4:1, High Potassium, 60 mEq K, packaged in 830 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0100-1.

Batch or Lot Expiration Information

Lot# 37-894304, Exp 04/29/2023; 37-894946, Exp 05/01/2023; 37-896482, Exp 05/07/2023; 37-897933, Exp 05/13/2023; 37-900461, Exp 05/22/2023

Recall Number: D-0683-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
558 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10% with CALCIUM, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0405-1.

Batch or Lot Expiration Information

Lot# 37-893806, Exp 04/28/2023; 37-894701, Exp 04/30/2023; 37-895626, Exp 05/05/2023; 37-897277, Exp 05/12/2023; 37-899175, Exp 05/19/2023; 37-900971, Exp 05/26/2023

Recall Number: D-0686-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
167 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4%/Dextrose 10%, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0408-1.

Batch or Lot Expiration Information

Lot# 37-896130, Exp 05/06/2023; 37-897957, Exp 05/13/2023; 37-899605, Exp 05/20/2023; 37-901357, Exp 05/27/2023

Recall Number: D-0653-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
338 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Reperfusate 4:1 low potassium, 15 mEq K, packaged in 477.5 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0008-1.

Batch or Lot Expiration Information

Lot# 37-893847, Exp 04/28/2023; 37-895646, Exp 05/05/2023; 37-897804, Exp 05/12/2023; 37-899236, Exp 05/19/2023

Recall Number: D-0697-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
485 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10% with low calcium and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0428-1.

Batch or Lot Expiration Information

Lot# 37-893805, Exp 04/28/2023; 37-894711, Exp 04/30/2023; 37-895258, Exp 05/04/2023; 37-896501, Exp 05/07/2023; 37-898160, Exp 05/13/2023; 37-900064, Exp 05/21/2023; 37-900620, Exp 05/25/2023

Recall Number: D-0675-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
226 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Maintenance 4:1 Plasmalyte, low potassium, low K, packaged in 1047 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0211-1.

Batch or Lot Expiration Information

Lot# 37-894309, 37-894321, Exp 04/29/2023; 37-896159, Exp 05/06/2023; 37-898510, Exp 05/15/2023; 37-900324, Exp 05/22/2023

Recall Number: D-0693-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
747 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0422-1.

Batch or Lot Expiration Information

Lot# 37-893819, Exp 04/28/2023; 37-894702, 37-894710, Exp 04/30/2023; 37-895215, Exp 05/04/2023; 37-897282, Exp 05/12/2023; 37-897921, Exp 05/13/2023; 37-898309, Exp 05/14/2023; 37-899199, Exp 05/19/2023; 37-900058, Exp 05/21/2023

Recall Number: D-0723-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
7632 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vancomycin added to 0.9% sodium chloride, 2 g/500 mL* (4 mg/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6078-1.

Batch or Lot Expiration Information

Lot# 37-884151, 37-884153, Exp 05/03/2023; 37-885670, 37-885869, 37-885900, Exp 05/09/2023; 37-886271, Exp 05/11/2023; 37-886857, 37-886862, 37-886865, 37-886923, Exp 05/15/2023; 37-889190, 37-889191, Exp 05/23/2023; 37-889596, Exp 05/24/2023; 37-890482, 37-890487, 37-890488, Exp 05/29/2023; 37-891230, Exp 05/31/2023; 37-892589, 37-892590, Exp 06/06/2023; 37-893779, 37-893780, 37-893781, Exp 06/12/2023; 37-894665, 37-894667, Exp 06/14/2023; 37-895608, 37-895625, Exp 06/19/2023; 37-896519, Exp 06/21/2023

Recall Number: D-0678-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
363 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Induction 8:1 non-enriched, HIGH POTASSIUM, 70 mEq K, packaged in 300 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0214-1.

Batch or Lot Expiration Information

Lot# 37-894310, Exp 04/29/2023; 37-895259, Exp 05/04/2023; 37-898303, Exp 05/14/2023; 37-901367, Exp 05/27/2023

Recall Number: D-0739-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
1300 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
heparin added to 0.9% sodium chloride, 2,500 units/250 mL* (10 units/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8000-1.

Batch or Lot Expiration Information

Lot# 37-888810, Exp 05/02/2023; 37-892217, Exp 05/16/2023; 37-895759, Exp 05/30/2023; 37-899174, Exp 06/13/2023

Recall Number: D-0657-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
24 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Transplant Solution (Plasma-Lyte A), packaged in 165 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0014-2.

Batch or Lot Expiration Information

Lot# 37-897801, Exp 05/12/2023

Recall Number: D-0755-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
1673 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
HyperLyte CR Injection, 250 mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8094-2, code 7128580942.

Batch or Lot Expiration Information

Lot# 37-885553, 37-885554, Exp 05/09/2023; 37-887923, 37-887924, Exp 05/18/2023; 37-890778, 37-890779, Exp 05/30/2023; 37-892847, Exp 06/07/2023; 37-895049, Exp 06/15/2023; 37-898480, 37-898481, Exp 06/29/2023

Recall Number: D-0663-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
308 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Maintenance 8:1 low potassium, 24 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0105-1.

Batch or Lot Expiration Information

Lot# 37-893846, Exp 04/28/2023; 37-895704, Exp 05/05/2023; 37-897079, Exp 05/11/2023; 37-897927, Exp 05/13/2023; 37-898814, Exp 05/18/2023; 37-900617, Exp 05/25/2023

Recall Number: D-0724-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
14205 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6092-1.

Batch or Lot Expiration Information

Lot# 37-883910, Exp 05/02/2023; 37-884221, Exp 05/03/2023; 37-884756, Exp 05/05/2023; 37-885358, Exp 05/08/2023; 37-885683, Exp 05/09/2023; 37-886267, 37-886268, Exp 05/11/2023; 37-886539, Exp 05/14/2023; 37-887458, 37-887459, Exp 05/16/2023; 37-888080, Exp 05/18/2023; 37-889192, Exp 05/23/2023; 37-889575, 37-889578, Exp 05/24/2023; 37-889852, 37-889855, Exp 05/25/2023; 37-890120, 37-890126, Exp 05/28/2023; 37-891485, 37-891491, Exp 06/01/2023; 37-892901, 37-892966, Exp 06/07/2023; 37-893236, 37-893237, Exp 06/08/2023; 37-893997, Exp 06/12/2023; 37-894777, Exp 06/14/2023; 37-895317, 37-895321, 37-895323, Exp 06/18/2023; 37-896201, Exp 06/20/2023; 37-896923, Exp 06/22/2023; 37-898558, Exp 06/29/2023

Recall Number: D-0704-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
2989 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 10 units added to Lactated Ringer's 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 72185-6036-1.

Batch or Lot Expiration Information

Lot# 37-891283, Exp 05/06/2023; 37-892501, Exp 05/12/2023; 37-894413, Exp 05/19/2023; 37-896228, Exp 05/26/2023; 37-896815, 37-896820, 37-896826, Exp 05/28/2023; 37-900126, Exp 06/10/2023

Recall Number: D-0666-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
613 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Induction 4:1 Plasma-Lyte/Tromethamine, High Potassium, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0111-1.

Batch or Lot Expiration Information

Lot# 37-894299, Exp 04/29/2023; 37-897051, Exp 05/11/2023; 37-897368, Exp 05/12/2023; 37-898794, Exp 05/18/2023; 37-899614, Exp 05/20/2023; 37-900608, Exp 05/25/2023

Recall Number: D-0720-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
27780 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vancomycin added to 0.9% sodium chloride, 1.25 g/250 mL* (5 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6074-1.

Batch or Lot Expiration Information

Lot# 37-883407, 37-883436, Exp 05/01/2023; 37-883796, 37-883797, 37-883800, 37-883802, 37-883806, Exp 05/02/2023; 37-884162, 37-884163, Exp 05/03/2023; 37-885332, 37-885336, 37-885337, Exp 05/08/2023; 37-885749, 37-885753, 37-885755, Exp 05/09/2023; 37-886008, 37-886027, 37-886031, 37-886035, Exp 05/10/2023; 37-886273, 37-886274, 37-886275, Exp 05/11/2023; 37-887448, 37-887457, Exp 05/16/2023; 37-887765, 37-887772, 37-887775, Exp 05/17/2023; 37-888062, 37-888072, Exp 05/18/2023; 37-888811, 37-888817, Exp 05/22/2023; 37-889193, 37-889208, 37-889210, Exp 05/23/2023; 37-889450, 37-889451, 37-889454, Exp 05/24/2023; 37-890940, 37-890941, 37-890952, Exp 05/30/2023; 37-891137, 37-891138, 37-891139, Exp 05/31/2023; 37-892633, 37-892634, 37-892635, Exp 06/06/2023; 37-892934, 37-892961, 37-892964, 37-892965, Exp 06/07/2023; 37-893524, Exp 06/11/2023; 37-893993, 37-893996, Exp 06/12/2023; 37-894465, 37-894466, 37-894467, 37-894468, Exp 06/13/2023; 37-894706, 37-894714, Exp 06/14/2023; 37-895680, 37-895682, Exp 06/19/2023; 37-896123, Exp 06/20/2023; 37-896564, 37-896579, 37-896586, Exp 06/21/2023

Recall Number: D-0715-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
6407 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
PHENYLephrine added to 0.9% sodium chloride, 10 mg/250 mL* (40 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6058-1.

Batch or Lot Expiration Information

Lot# 37-884272, Exp 05/03/2023; 37-887513, Exp 05/16/2023; 37-888083, Exp 05/18/2023; 37-889123, 37-889423, Exp 05/23/2023; 37-891563, Exp 06/01/2023; 37-892577, 37-892582, Exp 06/06/2023; 37-893248, 37-893257, Exp 06/08/2023; 37-894436, Exp 06/13/2023; 37-895805, Exp 06/19/2023; 37-898324, Exp 06/28/2023

Recall Number: D-0690-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
418 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 5% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0419-1.

Batch or Lot Expiration Information

Lot# 37-893810, Exp 04/28/2023; 37-894698, Exp 04/30/2023; 37-896144, Exp 05/06/2023; 37-897896, Exp 05/13/2023; 37-899172, Exp 05/19/2023

Recall Number: D-0660-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
544 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Induction 8:1 High Potassium, 108 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0102-1.

Batch or Lot Expiration Information

Lot# 37-894305, Exp 04/29/2023; 37-896153, Exp 05/06/2023; 37-897073, Exp 05/11/2023; 37-897925, 37-897941, Exp 05/13/2023; 37-899607, 37-899608, Exp 05/20/2023; 37-900320, Exp 05/22/2023

Recall Number: D-0679-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
325 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, Maintenance 8:1 non-enriched, low potassium, 24 mEq K, packaged in 300 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0215-1.

Batch or Lot Expiration Information

Lot# 37-895694, 37-896050, Exp 05/05/2023; 37-898304, Exp 05/14/2023; 37-899234, Exp 05/19/2023; 37-901375, Exp 05/27/2023

Recall Number: D-0727-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
5304 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
PHENYLephrine added to 0.9% sodium chloride, 25 mg/250 mL* (100 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7011-1.

Batch or Lot Expiration Information

Lot# 37-883924, Exp 05/02/2023; 37-884918, Exp 05/07/2023; 37-885677, Exp 05/09/2023; 37-887318, Exp 05/16/2023; 37-889211, Exp 05/23/2023; 37-889848, Exp 05/25/2023; 37-891150, Exp 05/31/2023; 37-892482, Exp 06/06/2023; 37-894484, Exp 06/13/2023; 37-896458, 37-896480, Exp 06/21/2023; 37-897967, Exp 06/27/2023; 37-898551, Exp 06/29/2023

Recall Number: D-0711-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
1332 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
oxyTOCIN 60 units added to 0.9% sodium chloride 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6045-1.

Batch or Lot Expiration Information

Lot# 37-883073, Exp 04/28/2023; 37-887776, Exp 05/17/2023; 37-889209, Exp 05/23/2023; 37-892588, Exp 06/06/2023; 37-894449, Exp 06/13/2023; 37-898552, Exp 06/29/2023

Recall Number: D-0681-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
690 syringes

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Modified del Nido Microplegia, packaged in 40 mL per syringe, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0219-1.

Batch or Lot Expiration Information

Lot# 37-893821, Exp 04/28/2023; 37-894813, 37-894815, Exp 04/30/2023; 37-895489, 37-895490, Exp 05/05/2023; 37-897810, 37-897811, Exp 05/13/2023; 37-899585, Exp 05/20/2023

Recall Number: D-0735-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
1735 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
phenylephrine 50 mg added to 0.9% sodium chloride 250 mL*, 200 mcg/mL*, 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7039-1.

Batch or Lot Expiration Information

Lot# 37-887056, 37-887057, 37-887059, Exp 05/15/2023; 37-893807, Exp 06/12/2023; 37-896880, Exp 06/22/2023

Recall Number: D-0719-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
13772 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vancomycin added to dextrose 5%, 1.25 g/250 mL* (5 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6073-1.

Batch or Lot Expiration Information

Lot# 37-883198, 37-883202, 37-883203, 37-883204, Exp 04/30/2023; 37-883799, Exp 05/02/2023; 37-884159, Exp 05/03/2023; 37-884888, 37-884892, 37-884899, 37-884901, Exp 05/07/2023; 37-886836, 37-886855, 37-886861, Exp 05/15/2023; 37-887381, Exp 05/16/2023; 37-887664, Exp 05/17/2023; 37-888256, 37-888259, 37-888267, Exp 05/21/2023; 37-888624, 37-888625, Exp 05/22/2023; 37-890038, 37-890041, 37-890042, Exp 05/28/2023; 37-890331, 37-890336, 37-890350, Exp 05/29/2023; 37-891163, Exp 05/31/2023; 37-892008, 37-892012, 37-892015, Exp 06/05/2023; 37-892882, 37-892884, Exp 06/07/2023

Recall Number: D-0749-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
4259 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
vasopressin 50 units added to 0.9% sodium chloride 50 mL*, 1 unit/mL*, 50 mL in 100 mL Partial Additive Bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-9002-1.

Batch or Lot Expiration Information

Lot# 37-883209, 37-883211, 37-883212, 37-883214, 37-883215, Exp 04/30/2023; 37-883776, Exp 05/02/2023; 37-884451, Exp 05/04/2023; 37-884805, 37-884806, 37-884808, 37-884810, 37-884811, Exp 05/07/2023; 37-886498, 37-886506, 37-886507, 37-886509, 37-886511, 37-886512, Exp 05/14/2023; 37-887319, 37-887321, Exp 05/16/2023; 37-889572, 37-889574, Exp 05/24/2023; 37-890881, 37-890883, 37-890884, 37-890887, Exp 05/30/2023; 37-892003, 37-892004, 37-892006, Exp 06/05/2023; 37-893157, Exp 06/08/2023; 37-893460, 37-893461, 37-893463, Exp 06/11/2023; 37-894619, 37-894648, 37-894650, Exp 06/14/2023; 37-895213, 37-895216, 37-895219, 37-895223, 37-895225, Exp 06/18/2023; 37-896813, Exp 06/22/2023; 37-897069, 37-897074, Exp 06/25/2023

Recall Number: D-0732-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
5207 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
heparin added to 0.9% sodium chloride, 5,000 units/500 mL* (10 units/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7023-1.

Batch or Lot Expiration Information

Lot# 37-888736, 37-888769, Exp 05/02/2023; 37-890465, 37-890483, Exp 05/09/2023; 37-892088, 37-892117, 37-892119, 37-892145, Exp 05/16/2023; 37-893759, 37-893765, Exp 05/23/2023; 37-895742, 37-895751, Exp 05/30/2023

Recall Number: D-0680-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
79 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Cardioplegia Solution, LEESBURG CARDIOPLEGIA, packaged in 1030.2 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0218-1.

Batch or Lot Expiration Information

Lot# 37-895256, Exp 05/04/2023; 37-898816, Exp 05/18/2023

Recall Number: D-0731-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
11117 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
heparin added to 0.9% sodium chloride, 4,000 units/1,000 mL* (4 units/mL), 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7022-1.

Batch or Lot Expiration Information

Lot# 37-888633, 37-888637, 37-888641, 37-888658, 37-888666, 37-888839, Exp 05/02/2023; 37-890332, 37-890383, 37-890394, 37-890424, 37-890428, 37-890442, Exp 05/09/2023; 37-892010, 37-892021, 37-892046, 37-892061, 37-892116, 37-892120, 37-892150, 37-892153, Exp 05/16/2023; 37-893467, 37-893469, 37-893470, 37-893471, 37-893508, 37-893512, 37-893519, Exp 05/22/2023; 37-893925, 37-893937, 37-893939, 37-893940, 37-893958, 37-893968, Exp 05/23/2023; 37-895218, 37-895220, 37-895224, 37-895231, 37-895236, 37-895305, 37-895306, Exp 05/29/2023; 37-895754, 37-895756, 37-895757, Exp 05/30/2023

Recall Number: D-0692-2023

Reason for Recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Initiated
04-28-2023
Reported
05-31-2023
Quantity
427 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
92253
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Central Admixture Pharmacy Services, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA.
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-22-2025
Product Description About Product Description
Full technical description of the product.
Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3.5%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0421-1.

Batch or Lot Expiration Information

Lot# 37-893804, Exp 04/28/2023; 37-894713, Exp 04/30/2023; 37-896134, Exp 05/06/2023; 37-896497, Exp 05/07/2023; 37-897310, Exp 05/12/2023; 37-899623, Exp 05/20/2023